Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Лечение пациентов с метастатическим поражением головного мозга Проект клинических рекомендаций
Голанов А.В., Бекяшев А.Х., Долгушин М.Б. и др. Лечение пациентов с метастатическим поражением головного мозга. Проект клинических рекомендаций. Современная онкология. 2015; 17 (3): 109–117.
________________________________________________
Golanov A.V., Bekiashev A.Kh., Dolgushin M.B. et al. The treatment of patients with metastatic brain tumors. Draft clinical guidelines. Journal of Modern Oncology. 2015; 17 (3): 109–117.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL. Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol 2010; 96 (1): 11–6.
2. Barnholtz-Sloan JS, Sloan AE, Davis FG et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncoly 2004; 22 (14): 2865–72.
3. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45 (7): 741–4.
4. Langley RE, Stephens RJ, Nankivell M et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncology (R Coll Radiol) 2013; 25 (3): e23–30.
5. Sperduto PW, Chao ST, Sneed PK et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77 (3): 655–61.
6. Barker FG 2nd. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer 2004; 100 (5): 999–1007.
7. Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280 (17): 1485–9.
8. Sun Ha Paek, Audu PB, Sperling MR et al. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005; 56 (5): 1021–34; discussion 1021–34.
9. Stark AM, Tscheslog H, Buhl R et al. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005; 28 (2): 115–9.
10. Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 362 (12): 1119–27.
11. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006; 64 (3): 898–903.
12. Bhatnagar AK, Kondziolka D, Lunsford LD, Flickinger JC. Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat 2007; 6 (3): 153–60.
13. Banfill KE, Bownes PJ, StClair SE et al. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival. Br J Neurosurg 2012; 26 (5): 674–8.
14. Won Seok Chang, Hae Yu Kim, Jin Woo Chang et al. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 2010; 113 Suppl: 73–8.
15. Kased N, Binder DK, McDermott MW et al. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys 2009; 75 (4): 1132–40.
16. Hanson PW, Elaimy AL, Lamoreaux WT et al. A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol 2012; 10: 176.
17. Hunter GK, Suh JH, Reuther AM et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012; 83 (5): 1394–8.
18. Muacevic A, Wowra B, Siefert A et al. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008; 87 (3): 299–307.
19. Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33 (6): 583–90.
20. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363 (9422): 1665–72.
21. Lippitz BE, Lindquist C, Paddick I et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev. 2014; 40(1): 48-59.
22. Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007; 60 (2): 277–83; discussion 283–4.
23. Rockoff MA. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 363 (6): 592; author reply 592–3.
2. Barnholtz-Sloan JS, Sloan AE, Davis FG et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncoly 2004; 22 (14): 2865–72.
3. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45 (7): 741–4.
4. Langley RE, Stephens RJ, Nankivell M et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncology (R Coll Radiol) 2013; 25 (3): e23–30.
5. Sperduto PW, Chao ST, Sneed PK et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77 (3): 655–61.
6. Barker FG 2nd. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer 2004; 100 (5): 999–1007.
7. Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280 (17): 1485–9.
8. Sun Ha Paek, Audu PB, Sperling MR et al. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005; 56 (5): 1021–34; discussion 1021–34.
9. Stark AM, Tscheslog H, Buhl R et al. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005; 28 (2): 115–9.
10. Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 362 (12): 1119–27.
11. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006; 64 (3): 898–903.
12. Bhatnagar AK, Kondziolka D, Lunsford LD, Flickinger JC. Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat 2007; 6 (3): 153–60.
13. Banfill KE, Bownes PJ, StClair SE et al. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival. Br J Neurosurg 2012; 26 (5): 674–8.
14. Won Seok Chang, Hae Yu Kim, Jin Woo Chang et al. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 2010; 113 Suppl: 73–8.
15. Kased N, Binder DK, McDermott MW et al. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys 2009; 75 (4): 1132–40.
16. Hanson PW, Elaimy AL, Lamoreaux WT et al. A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol 2012; 10: 176.
17. Hunter GK, Suh JH, Reuther AM et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012; 83 (5): 1394–8.
18. Muacevic A, Wowra B, Siefert A et al. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008; 87 (3): 299–307.
19. Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33 (6): 583–90.
20. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363 (9422): 1665–72.
21. Lippitz BE, Lindquist C, Paddick I et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev. 2014; 40(1): 48-59.
22. Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007; 60 (2): 277–83; discussion 283–4.
23. Rockoff MA. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 363 (6): 592; author reply 592–3.
________________________________________________
1. Robinson PD, Kalkanis SN, Linskey ME, Santaguida PL. Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines. J Neurooncol 2010; 96 (1): 11–6.
2. Barnholtz-Sloan JS, Sloan AE, Davis FG et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncoly 2004; 22 (14): 2865–72.
3. Delattre JY, Krol G, Thaler HT, Posner JB. Distribution of brain metastases. Arch Neurol 1988; 45 (7): 741–4.
4. Langley RE, Stephens RJ, Nankivell M et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncology (R Coll Radiol) 2013; 25 (3): e23–30.
5. Sperduto PW, Chao ST, Sneed PK et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010; 77 (3): 655–61.
6. Barker FG 2nd. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer 2004; 100 (5): 999–1007.
7. Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280 (17): 1485–9.
8. Sun Ha Paek, Audu PB, Sperling MR et al. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005; 56 (5): 1021–34; discussion 1021–34.
9. Stark AM, Tscheslog H, Buhl R et al. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005; 28 (2): 115–9.
10. Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 362 (12): 1119–27.
11. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006; 64 (3): 898–903.
12. Bhatnagar AK, Kondziolka D, Lunsford LD, Flickinger JC. Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery. Technol Cancer Res Treat 2007; 6 (3): 153–60.
13. Banfill KE, Bownes PJ, StClair SE et al. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival. Br J Neurosurg 2012; 26 (5): 674–8.
14. Won Seok Chang, Hae Yu Kim, Jin Woo Chang et al. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 2010; 113 Suppl: 73–8.
15. Kased N, Binder DK, McDermott MW et al. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Int J Radiat Oncol Biol Phys 2009; 75 (4): 1132–40.
16. Hanson PW, Elaimy AL, Lamoreaux WT et al. A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases. World J Surg Oncol 2012; 10: 176.
17. Hunter GK, Suh JH, Reuther AM et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012; 83 (5): 1394–8.
18. Muacevic A, Wowra B, Siefert A et al. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008; 87 (3): 299–307.
19. Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33 (6): 583–90.
20. Andrews DW, Scott CB, Sperduto PW et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363 (9422): 1665–72.
21. Lippitz BE, Lindquist C, Paddick I et al. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev. 2014; 40(1): 48-59.
22. Chang EL, Wefel JS, Maor MH et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 2007; 60 (2): 277–83; discussion 283–4.
23. Rockoff MA. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010; 363 (6): 592; author reply 592–3.
Авторы
А.В.Голанов1, А.Х.Бекяшев2, М.Б.Долгушин2, Г.Л.Кобяков1, Д.Р.Насхлеташвили2, А.В.Смолин3, А.В.Назаренко2, С.В.Медведев2, С.Р.Ильялов4, Е.Р.Ветлова1, С.М.Банов4
1 ФГБНУ НИИ нейрохирургии им. акад. Н.Н.Бурденко. 125047, Россия, Москва, 4-я Тверская-Ямская ул., д. 16;
2 ФГБУ Российский онкологический научный центр им. Н.Н.Блохина Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
3 ФГКУ Главный военный клинический госпиталь им. акад. Н.Н.Бурденко. 105229, Россия, Москва, Госпитальная пл., д. 3;
4 Центр Гамма-нож ФГБНУ НИИ нейрохирургии им. акад. Н.Н.Бурденко. 125047, Россия, Москва, 4-я Тверская-Ямская ул., д. 16, корп. 3
1 ФГБНУ НИИ нейрохирургии им. акад. Н.Н.Бурденко. 125047, Россия, Москва, 4-я Тверская-Ямская ул., д. 16;
2 ФГБУ Российский онкологический научный центр им. Н.Н.Блохина Минздрава России. 115478, Россия, Москва, Каширское ш., д. 23;
3 ФГКУ Главный военный клинический госпиталь им. акад. Н.Н.Бурденко. 105229, Россия, Москва, Госпитальная пл., д. 3;
4 Центр Гамма-нож ФГБНУ НИИ нейрохирургии им. акад. Н.Н.Бурденко. 125047, Россия, Москва, 4-я Тверская-Ямская ул., д. 16, корп. 3
________________________________________________
A.V.Golanov1, A.Kh.Bekiashev2, M.B.Dolgushin2, G.L.Kobiakov1, D.R.Naskhletashvili2, A.V.Smolin3, A.V.Nazarenko2, S.V.Medvedev2, S.R.Ilialov4, E.R.Vetlova1, S.M.Banov4
1 N.N.Burdenko Scientific-Research Institute for neurosurgery. 125047, Russian Federation, Moscow, 4-ia Tverskaia-Iamskaia ul., d. 16;
2 N.N.Blokhin Russian Cancer Research Center. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23;
3 Chief Military Clinical Hospital. 105229, Russian Federation, Moscow, Gospital'naia pl., d. 3;
4 Gamma Knife Center. 125047, Russian Federation, Moscow, 4-ia Tverskaia-Iamskaia ul., d. 16, korp. 3
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.